Among the remaining two samples, one had a dominant DN TCR-Vβ20 fraction at borderline frequency of 24,5% with clear CD161 expression (CLL #8, Figure 3) and only one CLL sample showed a dominant T cell clone without CD161 expression (CLL #9, Figure 3). The gene discussed is KLRB1; the disease is B-cell chronic lymphocytic leukemia.